Introduction
The term prostatitis can be used to describe a variety of clinical disorders. In the current National Institutes of Health (NIH) classification system there are four categories of prostatitis [1] . Type I prostatitis (acute bacterial prostatitis) is an acute, febrile bacterial infection of the prostate that is accompanied by bacteriuria and pyuria. Type II prostatitis (chronic bacterial prostatitis) indicates the presence of recurrent, low-grade bacterial infections of the prostate. The hallmarks of type II prostatitis include episodes of irritative voiding symptoms that are associated with bacteriuria and pyuria after prostate massage. Taken together, type I and II prostatitis account for 5% to 10% of all cases. Type III prostatitis, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), refers to the presence of bothersome pelvic pain symptoms without identifiable cause. Common symptoms include discomfort in the perineum, suprapubic region, and penis; pain associated with sexual activity; and bladder symptoms such as urinary frequency. This accounts for the majority of prostatitis cases encountered in the community [2] . Type IV prostatitis (asymptomatic inflammatory prostatitis) indicates the presence of prostate inflammation in the absence of symptoms; this is typically discovered during pathologic analysis of a prostate biopsy specimen. Unfortunately, current International Classification of Diseases-9 (ICD-9) coding categories do not correlate with the NIH classification system. Typical codes used to document these conditions include "acute prostatitis" (601.0), "chronic prostatitis" (601.1), and "prostatitis not otherwise specified" (601.9). Therefore, epidemiologic studies that use administrative data cannot determine the specific prevalence rates and costs of the four subtypes of prostatitis.
From 1990 to 1994, prostatitis accounted for almost 2 million outpatient visits per year, 8% of visits to urologists, and 1% of visits to primary care physicians in the United States [3] . Several estimates of prostatitis prevalence exist because of variations in the definitions used. For example, the estimated prevalence of medically diagnosed prostatitis is 9% [4]; the overall lifetime prevalence of prostatitis is 14% [5]; the prevalence of a self-reported history of prostatitis is 4% to 16% [4,6,7] ; and the prevalence of chronic prostatitis-like symptoms is 6% to 12% [8] [9] [10] [11] .
This paper reviews the current state of knowledge about the economic impact of prostatitis on society and on individuals with the condition. Where possible, data specific to type III prostatitis (CP/CPPS) are highlighted.
Health Care Use for Prostatitis: Results from the Urologic Diseases in America Project 
Outpatient care
Outpatient care for prostatitis includes hospital outpatient and physician office visits, ambulatory surgery procedures, and emergency department care. A slight decrease in visits for prostatitis over time was observed across the outpatient databases. This change could either be the result of a true decrease in visits for prostatitis or it could reflect a change over time in the way physicians code for prostatitis. Despite this slight decline, the absolute magnitude of the condition remains substantial.
Hospital outpatient visits
Data suggest that the rate of hospital outpatient visits increased during the 1990s. National Hospital Ambulatory Medical Care Survey data for 1994, 1996, 1998, and 2000 show that the aggregate age-adjusted hospital outpatient visit rate for prostatitis between 1994 and 2000 was 195 per 100,000 patients with prostatitis listed as any diagnosis. Medicare data for 1992, 1995, 1998, and 2001 show a 25% increase in the age-adjusted hospital outpatient visit rate between 1992 and 2001.
Physician office visits
The rate of physician office visits declined during the 1990s. According to National Ambulatory Medical Care Survey (NAMCS) data, there was a 25% decrease in the age-adjusted physician office visit rate between 1992 and 2000. The total number of physician office visits in 1992 was 2,176,818 (a rate of 2477 per 100,000 population) and in 2000 there were 1,795,643 visits (a rate of 1867 per 100,000 population). Like the NAMCS data, Medicare data for 1992, 1995, 1998, and 2001 show a decrease over time in the rate of age-adjusted physician office visits for patients with prostatitis aged 65 and older (2981 per 100,000 in 1992 versus 1828 per 100,000 in 2001). This corresponds to a 40% reduction in physician office visits between 1992 and 2001. Similarly, data from the Center for Health Care Policy and Evaluation (CHCPE) for the even years between 1994 and 2002 show that the unadjusted physician office visit rate for men with prostatitis who had commercial health insurance decreased over time. There was a 34% reduction in the office visit rate from 1994 to 2002 (450 per 100,000 in 1994 versus 296 per 100,000 in 2002).
Ambulatory surgery procedures
Visits to ambulatory surgery centers have also been decreasing. CHCPE data show that the rate of visits to an ambulatory surgery center by patients with a primary diagnosis of prostatitis and with commercial insurance decreased by 41% between 1994 and 2002 (11 versus 6.5 per 100,000). Similarly, data from the Centers for Medicare and Medicaid Services show a decrease over time of the age-adjusted rate of ambulatory surgery visits for patients with prostatitis aged 65 and older. Data from the National Survey of Ambulatory Surgery database showed that visit rates were fairly stable between 1994 and 1996 (annualized rate of 33 per 100,000 for prostatitis listed as any diagnosis), with visit rates highest for men aged 55 to 74 years (216 per 100,000). Three procedures, ranked in order of decreasing frequency, were associated with ambulatory surgery visits: cystoscopy, prostatic biopsy, and urethral dilation.
Economic impact
In the United States, an estimated $84 million was spent on treating prostatitis in 2000, according to inpatient and outpatient claims of patients with a primary diagnosis of prostatitis (Table 1) . This estimate consists of $35 million for inpatient services, $24 million for ambulatory surgery, $16 million for emergency department visits, and $4 million for hospital outpatient visits.
Treatment costs of prostatitis have increased over time. Between 1994 and 2002, mean costs increased for emergency department visits, physician outpatient visits, and inpatient hospitalization. In 2002, the average annual expenditure for privately insured individuals aged 18 to 64 years with a medical claim corresponding to a diagnosis of prostatitis was $5464 ($4038 for medical care and $1426 for prescription drugs) and $3704 for insured individuals without a medical claim relating 
